Matthew Oliver

Matthew T. Oliver

Associate, Corporate

Contact Information

moliver@osler.com

tel: 514.904.5382

Office

Montréal

Download vCard

Download Profile

Areas of Expertise

Bar Admission

Québec, 2012

Education

  • Laval University, L.L.B. (with distinction)
  • Bishop’s University, B.B.A.

Language(s)

French, English

Matthew is an associate in the Montreal office and is a member of the corporate group. He practices corporate and securities law with a focus on cross-border mergers and acquisitions, corporate finance and private equity fund formation. He has experience acting for private and public issuers, financial institutions, investment funds, as well as industry leaders in a range of sectors including natural resources, real estate and technology.

  • Promark Electronics Inc.

    Promark Electronics Inc. in its acquisition by Electrical Components International

  • Acasti Pharma Inc.

    Acasti in its definitive agreement to acquire Grace Therapeutics

  • Aceto

    Aceto in its acquisition of A&C

  • Bristol Myers Squibb

    Bristol Myers Squibb in its acquisition of Forbius

  • TPG

    TPG in its submission of a stalking horse bid for Cirque du Soleil’s assets in partnership with Fosun, Caisse de dépôt et placement du Québec and Investissement Québec

  • Ventas, Inc.

    Ventas in its acquisition of a high quality Canadian seniors housing portfolio valued at $2.4 billion in partnership with Le Groupe Maurice

  • L Brands

    L Brands with its sale of the La Senza business to Regent LP

  • Battery Ventures

    Battery Ventures’ $31 million investment in Robotiq

  • CAE Inc.

    CAE Inc. in its acquisition of Bombardier’s Business Aircraft Training (BAT) business for US$645 million

  • Hopper Inc.

    Hopper Inc. in its Series D Financing Round of US$100 million

  • ESI Technologies

    ESI Technologies in its nearly $10 million investment from Fondaction

  • Sphinx Resources Ltd.

    Sphinx Resources Ltd. in its Private Placement for approximately $260,000

  • Acasti Pharma Inc.

    Acasti Pharma Inc. in connection with its underwritten public offering of units for aggregate gross proceeds of $11.5 million

    • Sphinx Resources Ltd. in the creation of a new gold exploration company, Québec Precious Metals Corporation, and strategic investment by Goldcorp in such company
    • Information Ventures Inc., in relation to private equity fund formation and closing of initial subscriptions for limited partnership units.
    • Canadian counsel to H.I.G. Growth Partners, LLC in connection with acquisition of ConvertStar Incorporated dba Go2mobi.
    • Aéroports de Montréal, in connection with its offering of $200 million revenue bonds due June 2045.
    • ThermoCeramix Corporation in connection with its $7.5 million brokered private placement of common shares.
    • ThermoCeramix Corporation in connection with its Qualifying Transaction involving the reverse take-over of Springrock Capital Inc.
    • MEGA Brands in connection with its proposed US$460 million acquisition by Mattel.
    • Atrium Innovations Inc. (a Quebec based global leader in natural health products) in connection with its acquisition by the Permira funds, the Fonds de solidarité FTQ and Caisse de dépôt et placement du Québec in a transaction with an enterprise value of $1.1 billion.
    • Acasti Pharma Inc. in its US $23 million cross-border public offering of units comprised of common shares and warrants.
    • Neptune Technologies and Bioressources Inc. in connection with its $34.1 million underwritten public offering of common shares pursuant to the U.S.-Canada multijurisidictional disclosure system.
    • Miranda Technologies Inc. in connection with its publicly announced strategic review process, culminating in Belden Inc.’s $375 million acquisition of Miranda in 2012 by way of a take-over bid.
  • Find More

  • Canadian Bar Association
  • Barreau du Quebec